Indiana University Health Ball Memorial Cancer Center

Transcription

1 Indiana University Health Ball Memorial Cancer Center CANCER PROGRAM 2012 ANNUAL REPORT Statistical Data from 2011

2 Cancer Experts Working Together. Indiana University Health Ball Memorial Cancer Center serves Indiana s East Central Region. The center provides premier cancer care with leading edge medical and radiation oncology therapies along with patient specific clinical trials. Our unique partnership with IU Simon Cancer Center Indiana s only National Cancer Institute (NCI)-designated cancer center allows us to provide the assurance patients have the largest number of advanced treatment tools in the state to fight their cancer! IU Health Ball Memorial Cancer Center provides expert care from a team of specialists working together to help patients and their families cope with the immediate and long term effects of cancer. Services offered include: chemotherapy, radiation therapy, brachytherapy, prostate seed implants, stereotactic radiosurgery, intensity modulated radiation therapy, clinical trials, psychosocial evaluation, cancer education, nutritional support, mastectomy fittings, chaplaincy and spiritual support, community referrals, cancer rehabilitation, and blood replacement therapies. IU Health Ball Memorial Cancer Center is accredited with commendation as a Comprehensive Community Cancer Program by the Commission on Cancer. We have maintained this accreditation with this organization since This accreditation validates that IU Health Cancer Centers has the expert skill and knowledge to provide world-class cancer care close to home ANNUAL REPORT

3 Cancer Committee Patient Care Evaluation. Indiana University Health Ball Memorial Hospital Cancer Committee ACoS Standard 2.11 Prostate Cancer - Stage II First Course Treatment & Survival Indiana University Health Ball Memorial Hospital vs. National Cancer Data Base (NCDB) The purpose of this study was to compare first course treatment and survival rates of newly diagnosed prostate cancer patients at IU Health Ball Memorial Hospital versus the National Cancer Data Base. Review of available data determined that the majority of prostate cancer cases diagnosed and/or treated at IU Health Ball Memorial Hospital were stage II and there were not a sufficient number of cases in other stage categories to conduct a valid comparison. A comparison was made of all newly diagnosed prostate cancer cases from 2004 through A decrease in the number of prostate cancer cases at IU Health Ball Memorial Hospital was noted in 2005 and 2006 with the number of cases remaining relatively similar for the rest of the study. The NCDB also had a decrease in the number of prostate cancer cases in 2005 but remained relatively the same since that time. A comparison of Stage II cases was then conducted. Per review it was noted that stage II cases comprise over one-half of the total cases for both IU Health Ball Memorial Hospital and the NCDB. A comparison of first course treatment modalities for each year was conducted. In 2004 the majority of patients at IU Health Ball Memorial Hospital were treated with radiation therapy while NCDB data revealed surgery was the primary treatment modality ANNUAL REPORT

4 In 2005, surgery was again the primary treatment modality for NCDB and IU Health Ball Memorial Hospital cases, followed closely by radiation therapy and radiation therapy with hormonal therapy. In 2006, 30% of the patients at IU Health Ball Memorial Hospital were treated surgically or with radiation therapy and 36% of the patients were treated with radiation therapy In 2005 surgery was again the primary treatment modality for NCDB and IU Health Ball Memorial and Hospital hormonal cases followed therapy. closely NCDB by radiation data therapy revealed and radiation that the therapy primary with hormonal treatment therapy. modality was surgery, accounting for 40% of the patients. In % of the patients at IU Health Ball Memorial Hospital were treated surgically or with radiation therapy and 36% of the patients were treated with radiation therapy and hormonal therapy. NCDB data In revealed 2007, that the the primary treatment treatment modality modality was surgery, was accounting surgery for 40% both of IU the Health patients. Ball Memorial Hospital In 2007 and the for primary NCDB. treatment modality was surgery for both IU Health Ball Memorial Hospital and for NCDB. Nationally 50% of the patients diagnosed in 2008 were treated surgically but only 30% of the patients treated at IU Health Ball Memorial Hospital were treated surgically. The primary treatment modality for IU Nationally 50% of the patients diagnosed in 2008 were treated surgically but only 30% Health Ball Memorial Hospital was radiation therapy. of the After patients review treated it was noted at IU that Health less than Ball 5% of Memorial patients diagnosed Hospital and/or were treated treated IU Health surgically. Ball The Memorial Hospital and nationally did not receive any form of treatment. (Figure 1) primary treatment modality for IU Health Ball Memorial Hospital was radiation therapy. After review Indiana it was noted University that Health less than Ball Memorial 5% of patients Hospital diagnosed vs. National and/or Cancer treated Data Base at IU Health Ball Memorial Hospital and First nationally Course did Treatment not receive any form of treatment. (Figure 1) none other hormone therapy radiation/hormone therapy radiation therapy surgery 0% 10% 20% 30% 40% 50% 60% 2008 NCDB 2008 IUHBMH 2007 NCDB 2007 IUHBMH 2006 NCDB 2006 IUHBMH 2005 NCDB 2005 IUHBMH 2004 NCDB 2004 IUHBMH Figure 1 A comparison of survival statistics was also conducted involving patients diagnosed and/or treated in 1998 through Figure 2 reveals that there is no significant A comparison of survival statistics was also conducted involving patients diagnosed and/or treated in 1998 through Figure 2 reveals that there is no significant difference in the observed survival rates for IU Health Ball Memorial Hospital and NCDB. difference in the observed survival rates for IU Health Ball Memorial Hospital and NCDB ANNUAL REPORT

5 Indiana University Health Ball Memorial Hospital vs. National Cancer Data Base Observed Survival Indiana University Health Ball Memorial Hospital vs. National Cancer Data Base Observed Survival % 98% 96% 94% 92% 99% 99% 95% 97% 93% 94% 92% 90% 88% 86% 84% 82% 89% 89% 87% 80% 1 year 2 years 3 years 4 years 5 years IUHBMH NCDB Figure 2 The most important conclusion from the review of the data shows that survival rates for patients at IU Health Ball Memorial Hospital are similar to the NCDB. This confirms that patients at IU Health Ball Memorial Hospital The most important conclusion from the review of the data shows that survival rates are receiving appropriate treatment for prostate cancer. Although the first course of treatment at IU Health Ball for Memorial patients Hospital at IU may Health differ Ball from the Memorial NCDB cohort, Hospital the similar are similar survival to rates the for NCDB. the two This groups confirms show that that appropriate patients decision at IU making Health for Ball the treatment Memorial of prostate Hospital cancer are has receiving taken place. appropriate treatment for prostate Samuel Kim, cancer. MD Although the first course of treatment at IU Health Ball Memorial Hospital IU Health Ball Memorial Hospital Cancer Committee may differ from the NCDB cohort, the similar survival rates for the two groups show that appropriate Cancer Registry decision Report making for the treatment of prostate cancer has taken place. The Indiana University Health Ball Memorial Hospital Cancer Registry is a hospital-based cancer information database. The Cancer Registry has two Certified Tumor Registrars that collect, interpret, and record data involving patients diagnosed with and/or treated for a malignancy or a specific benign disease. The information collected includes demographics, diagnostic evaluations, treatment information, etc. Samuel Kim, MD IU Health Ball Memorial Hospital Cancer Committee ANNUAL REPORT

6 Cancer Registry Report. The IU Health Ball Memorial Hospital Cancer Registry is a hospital-based cancer information database. The Cancer Registry has two Certified Tumor Registrars that collect, interpret, and record data involving patients diagnosed with and/or treated for a malignancy or a specific benign disease. The information collected includes demographics, diagnostic evaluations, treatment information, etc. Data is reported to the Indiana State Cancer Registry monthly, and annually to the National Cancer Data Base per government mandates. Data is utilized to analyze state and national trends, analyze patient outcomes, etc. Data is reported to the Indiana State Cancer Registry monthly and annually to the National Cancer Data Base per government mandates. Data is utilized to analyze state and national trends, analyze patient outcomes, The etc. Cancer Registry s reference date is January 1, 1994 and there are 14,431 cases in the Cancer Registry database. Annual follow-up is conducted allowing the evaluation of The Cancer Registry s reference date is January 1, 1994 and there are 14,431 cases in the Cancer Registry treatment outcomes as well as comparison to national statistics. database. Annual follow-up is conducted allowing the evaluation of treatment outcomes as well as comparison to national statistics. In 2011, the top five sites for male patients were prostate (117 cases), lung (66 cases), In 2011 the top five sites for male patients were prostate (117 cases), lung (66 cases), urinary bladder (38 urinary bladder (38 cases), colorectal (33 cases), and lymph node/skin cancer (14 cases cases), colorectal (33 cases), and lymph node/skin cancer (14 cases each). The top five sites for female each). patients The were top breast five (148 sites cases), for lung female (61cases), patients colorectal were (44 breast cases), (148 skin (18 cases), lung and blood (61 system cases), colorectal malignancies (44 (17 cases), cases). A skin comparison (18 cases), to national and statistics blood as system follows: malignancies (17 cases). A comparison is made to national statistics as follows: Deleted: for Deleted: was Male Female Primary Site IUHBMH National Primary Site IUHBMH National Prostate 30% 29% Breast 36% 30% Lung & Bronchus 17% 14% Lung & Bronchus 15% 14% Colorectal 11% 9% Colorectal 9% 9% Urinary Bladder 10% 6% Uterine Corpus 4% 6% Melanoma of the Skin 3% 5% Thyroid 1% 5% Kidney & Renal Pelvis 4% 5% Non-Hodgkin Lymphoma 2% 4% Non-Hodgkin Lymphoma 3% 4% Melanoma of the Skin 4% 4% Oral Cavity & Pharynx 3% 3% Kidney & Renal Pelvis 4% 3% Leukemia 3% 3% Ovary 1% 3% Pancreas 2% 3% Pancreas 2% 3% Data is reported to the Indiana State Cancer Registry monthly and annually to the National Cancer Data Base per government mandates. Data is utilized to analyze state and national trends, analyze patient outcomes, etc ANNUAL REPORT

7 The National Cancer Data Base compiles reports reflecting treatment rendered for specific cancer sites. Comparisons are conducted involving Commission on Cancer approved programs. In Indiana there are approximately 49 approved programs and approximately 1,394 approved cancer programs nationally. The reports allow cancer programs the opportunity to examine data to determine if these performance rates are representative of the care provided at the institution. Performance rates are updated when data is amended or added. The graphs below reflect a comparison of treatment rendered for breast cancer cases diagnosed in Treatment: Radiation therapy is administered within1 year of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer. Treatment: Treatment: Radiation Radiation therapy therapy is is administered administered within1 within1 year year of of diagnosis diagnosis for for women women under under age age receiving receiving breast breast conserving conserving surgery surgery for for breast breast cancer. cancer. Treatment: Radiation therapy is administered within 1 year of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer. 84.8% 87.8% 91.7% 84.8% 84.8% 80% 82% 84% 86% 88% 87.8% 87.8% 90% 92% 94% 91.7% 91.7% All Coc Approved Programs Indiana IU Health Ball Memorial Hospital Deleted: Deleted: Deleted: 80% 82% 84% 86% 88% 90% 92% 94% 80% 82% 84% 86% 88% 90% 92% 94% Treatment: Combination All Coc Approved Programs Indiana IU Health Ball Memorial Hospital All Coc Approved chemotherapy Programs is considered Indiana IU Health or administered Ball Memorial Hospital within 4 months of diagnosis for women under 70 with AJCC T1cN0M0, or Stage II or III hormone receptor negative breast cancer. Treatment: Combination chemotherapy chemotherapy is considered is or considered administered within or administered 4 months of diagnosis within for 4 women months under 70 with AJCC T1cN0M0, or Stage II or III hormone receptor negative breast cancer. of diagnosis for women under 70 with AJCC T1cN0M0, or Stage II or III hormone receptor negative breast cancer. 87.4% Treatment: Combination chemotherapy is considered or administered within 4 months of diagnosis for women under 70 with AJCC T1cN0M0, or Stage II or III hormone receptor negative breast cancer. 93.2% 100% 87.4% 87.4% 80% 82% 84% 86% 88% 90% 92% 94% 93.2% 93.2% 96% 98% 100% 102% 100% 100% All Coc Approved Programs Indiana IU Health Ball Memorial Hospital 80% 82% 84% 86% 88% 90% 92% 94% 96% 98% 100% 102% 80% 82% 84% 86% 88% 90% 92% 94% 96% 98% 100% 102% All Coc Approved Programs Indiana IU Health Ball Memorial Hospital All Coc Approved Programs Indiana IU Health Ball Memorial Hospital Treatment: Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year of diagnosis for women with AJCC T1cN0M0, or stage II or III Treatment: hormone Tamoxifen receptor or positive third generation breast aromatase cancer. inhibitor is considered or administered within 1 year of Treatment: Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year of diagnosis for women with AJCC T1cN0M0, or stage II or III hormone receptor positive breast cancer. Treatment: Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year of diagnosis diagnosis for for women women with with AJCC AJCC T1cN0M0, T1cN0M0, or or stage stage II II or or III III hormone hormone receptor receptor positive positive breast breast cancer. cancer. 77.1% 75.8% 92.5% 77.1% 77.1% 0% 20% 40% 60% 75.8% 80% 75.8% 100% 92.5% 92.5% All CoC Approved Programs Indiana IU Health Ball Memorial Hospital 0% 0% 20% 20% 40% 40% 60% 60% 80% 80% 100% 100% All CoC Approved Programs Indiana IU Health Ball Memorial Hospital Conclusion: All IU CoC Health Approved Programs Ball Memorial Indiana IU exceeded Health Ball Memorial state Hospital as well as CoC programs for providing all three treatments within the specified time period ANNUAL REPORT

8 Leading Edge Cancer Clinical Trials and Research. At IU Health Ball Memorial Cancer Center we are passionate in our belief of the vitally important impact clinical research has on cancer care. We wholeheartedly support resources that can provide information to patients so they better understand the value and significance in participating in clinical trials. Treatment guidelines are developed from the results of clinical trials. Doctors across the country, IU Health Cancer Centers included, and around the world follow these guidelines so they can deliver the best possible treatment to their patients. Today there are about 12 million cancer survivors in the United States, mainly because of the work done in clinical trials. Every cancer treatment used today is a result of clinical trials and the people who took part in them. That is why it is so important to continue this research. There are many reasons why people take part in clinical trials, but most hope they will help themselves today and others in the future. These volunteers are doing something very important to improve cancer treatment. Indiana University Health Ball Memorial Cancer Center s Medical Oncology, Hematology and Radiation Oncology services offer clinical trials that provide patients with access to the latest cancer treatments. Clinical trials are the natural extension of the innovative research that further establishes IU Health Cancer services among the finest in the nation and are vital to the research and progress for new treatment programs. Clinical cancer trials available at IU Health Ball Memorial Hospital include: Breast Cancer Gastrointestinal Cancer Genitourinary Cancer Melanoma (skin cancer) Head and Neck Cancer Thoracic Cancer To learn more about the specific cancer clinical trials currently available at IU Health Ball Memorial Cancer Center please call or or visit: ANNUAL REPORT

9 Medical Oncology/Hematology Services. IU Health Ball Memorial Cancer Center s highly trained physicians specialize in hematology (treatment of blood disorders) and medical oncology (treatment of cancer). The medical oncologists provide individualized treatment plans for each patient based on the very latest in cancer and blood disorder research. Multidisciplinary Treatment Process Our expert staff of oncologists, researchers and health care professionals are recognized for a multidisciplinary approach to cancer treatment addressing the physical, spiritual and emotional needs of each patient. Our team works together at weekly cancer conferences to ensure the best possible treatment is provided for each patient. With a team of renowned cancer specialists, a full array of comprehensive services and convenient locations throughout Indiana, IU Health has unmatched reach and resources to meet the unique needs of cancer patients. Oncology Certified Nurses (OCN) Nurses who earn the OCN credential have proven their knowledge of cancer care by passing a national exam. The OCN certified nurse is experienced, knowledgeable, and informed about the latest in cancer treatments, research, symptom management and patient support. Certification is held or being pursued by all RNs at IU Health Ball Memorial Cancer Center. The expectation of certification demonstrates that our nurses have made an extra commitment to provide oncology expertise and experience which leads to improved quality and outcomes to patients in their care ANNUAL REPORT

10 Advanced Cancer Care IU Health Ball Memorial Hospital clinicians treat virtually every type of cancer, including breast, lung, colorectal, prostate, head and neck, and blood disorders. Along with advanced cancer care, we offer a full range of supportive care services. Advantages of our cancer program include: Multidisciplinary Care American College of Surgeons Commission on Cancer Accreditation (ACoS) Standard Treatment Options including Surgery, Chemotherapy, Radiation and Hormonal Therapy Convenient Locations Cancer Center Boutique Cancer Exercise Program Counseling Program Education and Resources for Patients, Families and Communities Oncology Dietitians Social Services Cancer Risk Assessment Free Screening and Prevention Programs Indiana University Health Ball Memorial Hospice Home Health Services Chaplaincy/Spiritual Care Inpatient Oncology Unit Financial Services Coordination ANNUAL REPORT

11 Medical Oncology/Hematology services are provided in Muncie, New Castle and Portland by our team of board-certified Medical Oncologists, Hematologists and Nurse Practitioners. Dejuania A. Brown, DO Dr. Brown is board-certified in medical oncology. She earned her doctor of osteopathic medicine degree from Philadelphia College of Osteopathic Medicine. Dr. Brown completed an internship and internal medicine residency at the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. She completed her fellowship in medical oncology at University of Medicine and Dentistry of New Jersey. William B. Fisher, MD, FACP Dr. Fisher is a board-certified physician specializing in hematology and oncology. He earned a doctor of medicine degree from the University of Pennsylvania School of Medicine, where he was selected for Alpha Omega Alpha membership. He completed an internship and residency at University Hospitals of Cleveland and is a clinical professor of medicine at Indiana University. Sulfi Ibrahim, MD Dr. Ibrahim is board-certified in hematology, medical oncology and internal medicine. He earned his doctor of medicine degree from the University of Maryland where he also received an undergraduate degree in molecular biology. Dr. Ibrahim completed his residency in internal medicine at Drexel University. He completed his fellowship in hematology oncology at the Milton S. Hershey Medical School ANNUAL REPORT

12 Joseph E Spahr, MD Dr. Spahr is board-certified in hematology and medical oncology. He earned a doctor of medicine degree from Indiana University School of Medicine. He completed an internship and residency in internal medicine at Ball Memorial Hospital where he was Chief Resident. Dr. Spahr completed his fellowship in hematology oncology at the University of Utah/Huntsman Cancer Institute in Salt Lake City, Utah. Michael J. Williamson, JR, DO Dr. Williamson is board-certified in hematology and medical oncology. He earned a doctor of osteopathic medicine degree from Michigan State University College of Osteopathic Medicine. Dr. Williamson completed an internship and residency in internal medicine at Ball Memorial Hospital. He completed his fellowship in hematology oncology at Saint Louis University in St. Louis, Missouri. Abby Koons, AANP-C, AOCNP Abby is an Adult Nurse Practitioner with American Academy of Nurse Practitioners Board Certification. She is an Advanced Oncology Certified Nurse Practitioner and a member of the Oncology Nursing Society and American Academy of Nurse Practitioners. Abby received her Bachelor of Science in Nursing from Indiana University East and her Master of Science as Nurse Practitioner degree from Ball State University. Marjorie Wiseman, FNP-C, AOCNP Margie is a Family Nurse Practitioner with American Nursing Credentialing Center Board Certification. She is an Advanced Oncology Certified Nurse Practitioner and a member of the American Academy of Nurse Practitioners, Coalition of Advanced Practice Nurses of Indiana and Advanced Practice Nurses of East Central Indiana. Margie received her Master of Science in Nursing, Family Nurse Practitioner degree from Ball State University ANNUAL REPORT

13 Radiation Oncology. Indiana University Health Ball Memorial Cancer Center s Radiation Oncology department offers a full range of expert care and is committed to providing the very latest in cancer treatment. We are one of the most technologically advanced radiation oncology programs in the state and are proud to provide the following additions to our already comprehensive list of services: 4DCT 3D imaging for treatment planning is now the standard for therapy planning, but with 4D, we add the extra dimension of motion. Tumors within the chest and abdomen can move with respiration, so this technique incorporates the patient s tumor motion into the design of the treatment field. With this precision technique, more dose can be given to the tumor, and potential side effects can be reduced. SRS - Stereotactic Radiosurgery Stereotactic radiosurgery is a nonsurgical, painless technology that can reduce or eliminate certain lesions and tumors in the brain, many previously considered inopereable. SRS for the brain is available at IU Health Ball Memorial Cancer Center and is comparable to Gammaknife. IGRT - Image-Guided Radiation Therapy Dynamic targeting IGRT pinpoints daily changes in the location of the tumor by using images taken just prior to treatment. These changes may be caused by internal organ movement due to bowel changes, weight loss, or even breathing. These images are then matched to the original planning images to see if the tumor has shifted. The software can instantly calculate tiny movements needed to align the tumor perfectly with the radiation beam. The increased precision of this technique allows healthy tissue and surrounding organs to be spared while focusing the dose to the tumor. By decreasing the dose to normal tissue, and decreasing possible complications, we are able to increase the total dose to the tumor for better control ANNUAL REPORT

14 SBRT - Stereotactic Body Radiation Therapy SBRT is stereotactic radiosurgery for tumors in areas of the body, such as the spine, liver or lung, where a tumor may not be treatable by conventional methods because of its proximity to critical structures. This procedure can deliver a highly precise dose of radiation around these critical organs, such as to a tumor in the spine, where the radiation dose needs to curve around the spinal cord. MammoSite 5-day Targeted Radiotherapy For some early stage breast cancer patients, this is an alternative to a conventional 5-7 week course of radiation therapy. The MammoSite procedure is done in cooperation with a surgeon who places the device in the lumpectomy site after breast cancer surgery. The device is then used to deliver radiation treatment over a five day period. MammoSite offers the latest in Multilumen therapy which optimizes patient dose while delivering treatment in a shorter amount of time. RapidArc /IMRT IU Health Ball Memorial Hospital is one of the first facilities in the state to offer this technology. RapidArc/IMRT, the next dimension in speed and precision, is the latest in image-guided, intensity-modulated radiation therapy (IMRT). RapidArc is a new treatment technique that minimizes the amount of radiation delivered to healthy structures while aggressively treating cancerous tissue. This form of therapy delivers treatment up to five times faster and more accurately than other conventional systems and is one of the most advanced methods of radiation delivery. RapidArc s speed and precision helps to enhance patient comfort by reducing treatment time ANNUAL REPORT

15 Radiation Oncology services are provided by our board-certified radiation oncologists. Stephen Tilmans, MD Dr. Tilmans is a board-certified radiation oncologist and is a member of IU Health Ball Memorial Hospital s clinical staff. A graduate of Indiana University School of Medicine, he completed his internship in Radiation Oncology at St. Vincent Hospital, Indianapolis, and his residency in Radiation Oncology at Indiana University Medical Center. He is an assistant clinical professor at Indiana University Medical Center. He is affiliated with the national cancer research organization, Radiation Therapy Oncology Group (RTOG). Fred Francis, MD Dr. Francis is a board-certified radiation oncologist and is a member of IU Health Ball Memorial Hospital s clinical staff. A graduate of the University of Kentucky College of Medicine, he completed his internship in internal medicine at the University of Kentucky, and his residency in Radiation Oncology at the University of Cincinnati. Dr. Francis also has a Master s degree in Health Physics from Georgia Institute of Technology. He is affiliated with the national cancer research organization, Radiation Therapy Oncology Group (RTOG). Yunjie Xie Lin, MD Dr. Lin is a board-certified radiation oncologist and is a member of IU Health Ball Memorial Hospital s clinical staff. A graduate of the Suzhou Medical School in China, she completed her internship in Cancer Biology at Wayne State University School of Medicine, Detroit. Dr. Lin completed her residency in Radiation Oncology and fellowship in Cancer Biology and Genetherapy at the Henry Ford Hospital in Detroit, Michigan. She is affiliated with the national cancer research organization, Radiation Therapy Oncology Group (RTOG). John Jacobs, MD Dr. Jacobs is a board-certified radiation oncologist and is a member of IU Health Ball Memorial Hospital s clinical staff. He is affiliated with the national cancer research organization, Radiation Therapy Oncology Group (RTOG). Dr. Jacobs received his undergraduate degree from Harvard University and medical degree from Loyola University. He received his Radiation Oncology training at the Medical College of Wisconsin ANNUAL REPORT

16 Cancer Prevention, Screening and Education Programs Cancer Education Program held at the Community Center for Vital Aging. Cancer myths as well as cancer prevention and early detection were discussed. Sixteen people (mostly older adults) attended the program. Breast self exam and testicular self exam instruction was presented to high school students at Jay County High School. Two hundred sixty-seven students received this instruction and were able to ask a health professional about cancer. Cancer Free Lungs Tobacco Education Program was presented to 91 middle school and high school students at Wes Del Jr. and Sr. High School. Students learned the dangers of tobacco use, the tactics of the tobacco industry to entice them, and were encouraged to choose who they want to be, related to tobacco use. Right Choices Right Now youth cancer education video was presented to 287 students at two elementary schools. Fourth and 5th grade students learned even as 10 and 11 year olds they are making choices that may affect their cancer risk later in life. Children were encouraged to make good choices regarding tobacco, sun safety, nutrition, and exercise. P3 Pink, Power and Praise a breast cancer education program targeting African American women. The program incorporates breast health education with spirituality and praise. Women listen to guest speakers about the importance of early detection and hear riveting stories from cancer survivors. One hundred fifty women attended this program. Health Education students at Ball State University were given instruction on teaching high school students about breast and testicular cancer and how to do self exams. Academic standards were reviewed and helpful websites and resources were discussed. Fifteen students participated in the class ANNUAL REPORT

17 Colorectal Cancer Awareness Campaign March, IU Health Ball Memorial Cancer Center collaborated with the American Cancer Society, Cancer Services East Central Indiana Little Red Door and other local agencies to provide colorectal cancer awareness and free screenings. Education materials were distributed to major employers in Delaware County, physician offices, health centers, and other companies that could be used for display boards, payroll stuffers, blasts, newsletters, etc. A Lunch and Lifestyle at Union Baptist Church was presented on colorectal cancer. An Ask the Expert column was featured in the local newspaper. Two radio broadcasts, featuring a local colorectal cancer survivor and an oncologist, highlighted the importance of screening. Children from an elementary school, as well as the Boys and Girls Club, sent grandparent postcards encouraging older adults to be screened. All Dairy Queen locations in Muncie held DQ Goes Blue Day. Information was available about colorectal cancer, and patrons wearing blue received discount offers. African American churches participated in Blue Sunday where individuals were asked to wear blue to church, and ministers helped spread the word about screening. IU Health Ball Memorial Hospital offered free fecal occult blood tests to anyone upon request. Forty test kits were distributed during March, September and October, 2011 IU Health Ball Memorial Cancer Center helped to coordinate two breast cancer awareness events/walks in Muncie. In September, the Reaching Out 5k walk/run attracted over 125 participants. The event offered information about breast cancer, survivor stories, and a chance to raise awareness. In October, IU Health Ball Memorial Cancer Center hosted the American Cancer Society Making Strides against Breast Cancer Walk. Nearly 400 people participated in this event ANNUAL REPORT

18 Health Fairs 2011 IU Health Ball Memorial Cancer Center participated in 14 health fairs in These health fairs varied from schools and churches to senior centers and community health fairs. Approximately 3500 people were reached at these health fairs. Cancer Screening Programs 2011 January, 2011 Free Cervical Cancer Screening. A free Pap test and HPV test offered in conjunction with local gynecologists offices and 97 women were screened. May, 2011 Free Skin Cancer Screenings. Free skin cancer screenings were offered in four surrounding counties in conjunction with local dermatologists offices and 274 people received a screening. October, 2011 Free Cervical Cancer Screening. A free Pap test and HPV test offered in conjunction with Family Practice Residency Clinic. Eighty women were screened. Ongoing free colorectal cancer screening. Take at home fecal occult blood tests are available at any time per request to the IU Health Ball Memorial Cancer Center with 73 test kits being mailed to individuals in Reaching Out Breast Health Program participants were as follows: Education 780 (some of whom also received screening services) Screening Services ANNUAL REPORT

19 Cancer Center Supportive Services. IU Health Ball Memorial Cancer Center is committed to providing expert medical treatment complemented by supportive care. Our supportive care staff provides services that address the emotional, spiritual and educational needs of individuals whose lives have been touched by cancer. Social services, pastoral care, and cancer counseling help patients and their families manage the effect of cancer on their lives. Support groups, education programs, and a cancer exercise program can help families adjust to the changes that occur when cancer is diagnosed and treated. These Supportive Services ensure a continuum of care for patients diagnosed, treated, and cared for at our cancer center. Please let us know what we can do to help meet your needs and exceed your expectations of compassionate cancer care. Our supportive services include: Counselors Social Workers Pharmacists Chaplains Cancer Exercise Specialist Certified Mastectomy Fitter/Cancer Center Boutique Dietitian Financial Services Representatives Cancer Education Community Referrals (Cancer Services East Central Indiana - Little Red Door - American Cancer Society) For more information please call IU Health Ball Memorial Cancer Center at ANNUAL REPORT

20 2011 Cancer Committee Membership. Chairman: Thomas Whiteman, MD Physician Members: William Fisher, MD Medical Oncology Joseph Songer, MD Hospice Director, Ex-Officio Michael Williamson, DO Medical Oncology Joseph Spahr, MD Medical Oncology Dejuania Brown, DO Medical Oncology Sulfi Ibrahim, MD Medical Oncology Paul Stewart, MD Surgery Yunjie Lin, MD Radiation Oncology Roberto Darroca, MD Gynecology Samuel Kim, MD Urology George Branam, MD Pathology Richard Pearson, MD Pathology Jamison Wilson, MD Diagnostic Radiology Mazen Alsatie, MD Gastroenterology Neal Coleman, MD Pain/Palliative Care Coordinators: Becky Butts, BSW, Community Outreach Coordinator Debbie Oliver, CTR, Cancer Registry Quality Coordinator Laura Crampton, RN, Quality Improvement Coordinator Tracy Loar, CTR, Cancer Conference Coordinator Ancillary Members: Terry Pence, RPh, MBA, Service Line Leader Rod Stevens, RN, BSN, Operations Manager, Medical Oncology Physician Administrator Rhonda Harmon, Manager, Radiation Oncology Melody Stanley, MS, Coordinator, Patient Education & Support Services Patricia Avila, RN, AOCNS, MSN Clinical Nurse Specialist Abby Koons, AANP-C, AOCNP - Medical Oncology Marjorie Wiseman,FNP-C, AOCNP - Medical Oncology Sherry Simmonds, RN, CCRP, Coordinator, Clinical Research Angie Patterson, RN, CCRP, Coordinator, Clinical Research Brenda Sloan, RN, CCRP, Coordinator, Clinical Research Dani Williams, RN, OCN, Nurse Manager, Inpatient Oncology Mary Rigel, Manager, Cancer Center Boutique Don Nicholas, PhD, Coordinator, Cancer Counseling Services Matthew Douglass, MS, ACSM/ACS, Cancer Exercise Specialist Courtney Sutliff, LCSW, Social Work RuthAnn Tolle, RN, Manger, IU Health Ball Memorial Hospice Cecilia Williams, Health Initiatives Coordinator, Great Lakes Division, Mid Indiana Area, American Cancer Society Julie Hankins, Executive Director, Cancer Services of East Central Indiana, Little Red Door Rev. James Hilleson, Director, Spiritual Care and Chaplaincy Services Jennifer Muterspaugh, RD, Oncology Dietitian ANNUAL REPORT

21 IU Health Ball Memorial Hospital Cancer Center Clinical Research IU Health Ball Memorial Cancer Center: or Clinical Research IU Health Ball Memorial Hospital: IU Health Ball Memorial Cancer Center: IU Health Ball Memorial Cancer Center Boutique: Cancer Counseling Services: Financial Services Representative: Cancer Center Dietitian: Cancer Education & Supportive Services: Cancer Prevention and Screening: Clinical Nurse Specialist: Cancer Registry: , Spiritual Care and Chaplaincy Services: Comprehensive Breast Center: Cancer Exercise Program: Family Library: IU Health Ball Memorial Hospice: Inpatient Oncology Unit: Lymphedema Clinic: Medical Oncology/Hematology: Radiation Oncology: Social Services: References: ACS Facts and Figures ANNUAL REPORT

22 2012 Indiana University Health 12/31/12 iuhealth.org/ball-memorial Follow us on